COHEN & STEERS INC (CNS) Stock Fundamental Analysis
NYSE:CNS - New York Stock Exchange, Inc. - US19247A1007 - Common Stock
CNS gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 224 industry peers in the Capital Markets industry. Both the health and profitability get an excellent rating, making CNS a very profitable company, without any liquidiy or solvency issues. While showing a medium growth rate, CNS is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
In the past year CNS was profitable.
In the past year CNS had a positive cash flow from operations.
CNS had positive earnings in each of the past 5 years.
In the past 5 years CNS always reported a positive cash flow from operatings.
1.2 Ratios
CNS has a better Return On Assets (18.59%) than 98.17% of its industry peers.
CNS has a Return On Equity of 27.55%. This is amongst the best in the industry. CNS outperforms 95.89% of its industry peers.
CNS has a better Return On Invested Capital (23.22%) than 99.09% of its industry peers.
CNS had an Average Return On Invested Capital over the past 3 years of 39.03%. This is significantly above the industry average of 6.66%.
The last Return On Invested Capital (23.22%) for CNS is well below the 3 year average (39.03%), which needs to be investigated, but indicates that CNS had better years and this may not be a problem.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 18.59% | ||
| ROE | 27.55% | ||
| ROIC | 23.22% |
ROA(3y)28.61%
ROA(5y)28.25%
ROE(3y)55.79%
ROE(5y)54.86%
ROIC(3y)39.03%
ROIC(5y)41.91%
1.3 Margins
With a decent Profit Margin value of 27.23%, CNS is doing good in the industry, outperforming 69.41% of the companies in the same industry.
In the last couple of years the Profit Margin of CNS has declined.
Looking at the Operating Margin, with a value of 32.49%, CNS is in line with its industry, outperforming 57.99% of the companies in the same industry.
In the last couple of years the Operating Margin of CNS has declined.
CNS has a Gross Margin of 89.06%. This is amongst the best in the industry. CNS outperforms 90.87% of its industry peers.
CNS's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 32.49% | ||
| PM (TTM) | 27.23% | ||
| GM | 89.06% |
OM growth 3Y-2.76%
OM growth 5Y-2.73%
PM growth 3Y13.73%
PM growth 5Y-2.48%
GM growth 3Y0.84%
GM growth 5Y0.47%
2. Health
2.1 Basic Checks
The number of shares outstanding for CNS has been increased compared to 1 year ago.
Compared to 5 years ago, CNS has more shares outstanding
There is no outstanding debt for CNS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
CNS has an Altman-Z score of 12.54. This indicates that CNS is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of CNS (12.54) is better than 95.89% of its industry peers.
CNS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 12.54 |
ROIC/WACCN/A
WACCN/A
2.3 Liquidity
A Current Ratio of 0.92 indicates that CNS may have some problems paying its short term obligations.
With a Current ratio value of 0.92, CNS perfoms like the industry average, outperforming 43.38% of the companies in the same industry.
CNS has a Quick Ratio of 0.92. This is a bad value and indicates that CNS is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of CNS (0.92) is comparable to the rest of the industry.
CNS does not score too well on the current and quick ratio evaluation. However, as it has excellent solvency and profitability, these ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.92 | ||
| Quick Ratio | 0.92 |
3. Growth
3.1 Past
The earnings per share for CNS have decreased by -4.41% in the last year.
Measured over the past 5 years, CNS shows a small growth in Earnings Per Share. The EPS has been growing by 3.27% on average per year.
Looking at the last year, CNS shows a small growth in Revenue. The Revenue has grown by 0.21% in the last year.
CNS shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.14% yearly.
EPS 1Y (TTM)-4.41%
EPS 3Y3.13%
EPS 5Y3.27%
EPS Q2Q%10%
Revenue 1Y (TTM)0.21%
Revenue growth 3Y4.63%
Revenue growth 5Y5.14%
Sales Q2Q%7.65%
3.2 Future
Based on estimates for the next years, CNS will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.40% on average per year.
Based on estimates for the next years, CNS will show a small growth in Revenue. The Revenue will grow by 6.56% on average per year.
EPS Next Y5.76%
EPS Next 2Y13.24%
EPS Next 3Y11.84%
EPS Next 5Y9.4%
Revenue Next Year6.14%
Revenue Next 2Y11.7%
Revenue Next 3Y10.3%
Revenue Next 5Y6.56%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 30.94 indicates a quite expensive valuation of CNS.
71.69% of the companies in the same industry are cheaper than CNS, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 28.29, CNS is valued at the same level.
Based on the Price/Forward Earnings ratio of 24.04, the valuation of CNS can be described as rather expensive.
CNS's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. CNS is more expensive than 65.30% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 24.44. CNS is around the same levels.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 30.94 | ||
| Fwd PE | 24.04 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, CNS is valued a bit cheaper than 63.93% of the companies in the same industry.
The rest of the industry has a similar Price/Free Cash Flow ratio as CNS.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 44.28 | ||
| EV/EBITDA | 25.53 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The excellent profitability rating of CNS may justify a higher PE ratio.
PEG (NY)5.37
PEG (5Y)9.48
EPS Next 2Y13.24%
EPS Next 3Y11.84%
5. Dividend
5.1 Amount
CNS has a Yearly Dividend Yield of 2.68%. Purely for dividend investing, there may be better candidates out there.
CNS's Dividend Yield is comparable with the industry average which is at 9.45.
Compared to an average S&P500 Dividend Yield of 2.28, CNS has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.68% |
5.2 History
The dividend of CNS decreases each year by -9.78%.
CNS has been paying a dividend for at least 10 years, so it has a reliable track record.
The dividend of CNS decreased in the last 3 years.
Dividend Growth(5Y)-9.78%
Div Incr Years2
Div Non Decr Years2
5.3 Sustainability
CNS pays out 86.70% of its income as dividend. This is not a sustainable payout ratio.
DP86.7%
EPS Next 2Y13.24%
EPS Next 3Y11.84%
COHEN & STEERS INC
NYSE:CNS (1/22/2025, 10:43:08 AM)
87.25
-1.95 (-2.19%)
Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)
Earnings (Next)
Inst Owners62.19%
Inst Owner Change-0.02%
Ins Owners23.05%
Ins Owner Change-2.01%
Market Cap4.41B
Analysts76.67
Price Target108.63 (24.5%)
Short Float %5.99%
Short Ratio8.79
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.68% |
Yearly Dividend2.3
Dividend Growth(5Y)-9.78%
DP86.7%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.89%
Min EPS beat(2)-2.26%
Max EPS beat(2)0.49%
EPS beat(4)2
Avg EPS beat(4)-0.13%
Min EPS beat(4)-2.38%
Max EPS beat(4)3.65%
EPS beat(8)4
Avg EPS beat(8)1.04%
EPS beat(12)8
Avg EPS beat(12)2.87%
EPS beat(16)12
Avg EPS beat(16)3.94%
Revenue beat(2)1
Avg Revenue beat(2)2.71%
Min Revenue beat(2)-0.79%
Max Revenue beat(2)6.21%
Revenue beat(4)1
Avg Revenue beat(4)-0.34%
Min Revenue beat(4)-3.96%
Max Revenue beat(4)6.21%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)37.42%
EPS NQ rev (1m)0%
EPS NQ rev (3m)13.38%
EPS NY rev (1m)0%
EPS NY rev (3m)2.01%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)11.2%
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.18%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 30.94 | ||
| Fwd PE | 24.04 | ||
| P/S | 8.88 | ||
| P/FCF | 44.28 | ||
| P/OCF | 36.63 | ||
| P/B | 8.98 | ||
| P/tB | 9.36 | ||
| EV/EBITDA | 25.53 |
EPS(TTM)2.82
EY3.23%
EPS(NY)3.63
Fwd EY4.16%
FCF(TTM)1.97
FCFY2.26%
OCF(TTM)2.38
OCFY2.73%
SpS9.83
BVpS9.71
TBVpS9.33
PEG (NY)5.37
PEG (5Y)9.48
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 18.59% | ||
| ROE | 27.55% | ||
| ROCE | 30.61% | ||
| ROIC | 23.22% | ||
| ROICexc | 29.09% | ||
| ROICexgc | 33.11% | ||
| OM | 32.49% | ||
| PM (TTM) | 27.23% | ||
| GM | 89.06% | ||
| FCFM | 20.05% |
ROA(3y)28.61%
ROA(5y)28.25%
ROE(3y)55.79%
ROE(5y)54.86%
ROIC(3y)39.03%
ROIC(5y)41.91%
ROICexc(3y)79.63%
ROICexc(5y)73.18%
ROICexgc(3y)100.16%
ROICexgc(5y)90.53%
ROCE(3y)51.46%
ROCE(5y)55.25%
ROICexcg growth 3Y-14.15%
ROICexcg growth 5Y-2.68%
ROICexc growth 3Y-13.72%
ROICexc growth 5Y-2.45%
OM growth 3Y-2.76%
OM growth 5Y-2.73%
PM growth 3Y13.73%
PM growth 5Y-2.48%
GM growth 3Y0.84%
GM growth 5Y0.47%
F-Score4
Asset Turnover0.68
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 188.31% | ||
| Cap/Sales | 4.19% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 69.84% | ||
| Profit Quality | 73.65% | ||
| Current Ratio | 0.92 | ||
| Quick Ratio | 0.92 | ||
| Altman-Z | 12.54 |
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)410.56%
Cap/Depr(5y)269.7%
Cap/Sales(3y)4.28%
Cap/Sales(5y)2.82%
Profit Quality(3y)78.77%
Profit Quality(5y)90.49%
High Growth Momentum
Growth
EPS 1Y (TTM)-4.41%
EPS 3Y3.13%
EPS 5Y3.27%
EPS Q2Q%10%
EPS Next Y5.76%
EPS Next 2Y13.24%
EPS Next 3Y11.84%
EPS Next 5Y9.4%
Revenue 1Y (TTM)0.21%
Revenue growth 3Y4.63%
Revenue growth 5Y5.14%
Sales Q2Q%7.65%
Revenue Next Year6.14%
Revenue Next 2Y11.7%
Revenue Next 3Y10.3%
Revenue Next 5Y6.56%
EBIT growth 1Y-6.91%
EBIT growth 3Y1.74%
EBIT growth 5Y2.27%
EBIT Next Year9.43%
EBIT Next 3Y22.42%
EBIT Next 5Y10.19%
FCF growth 1Y38.71%
FCF growth 3Y9.87%
FCF growth 5Y10.72%
OCF growth 1Y59.35%
OCF growth 3Y24.46%
OCF growth 5Y18.82%